Trial Profile
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: An Open-label, Randomized Clinical Trial in Brazil
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2024
Price :
$35
*
At a glance
- Drugs Miltefosine (Primary) ; Pentoxifylline (Primary) ; Meglumine antimonate
- Indications Leishmaniasis
- Focus Therapeutic Use
- 11 Jan 2024 Planned End Date changed from 1 Aug 2025 to 1 Aug 2026.
- 11 Jan 2024 Planned primary completion date changed from 1 Aug 2024 to 1 Aug 2025.
- 23 May 2022 Status changed from recruiting to active, no longer recruiting.